Axsome Therapeutics (NASDAQ:AXSM) said a long-term Phase 3 study of its drug AXS-12 for the treatment of narcolepsy with cataplexy has met its primary endpoint. The study showed AXS-12 was able to ...

Maxeon Solar Technologies ( NASDAQ: MAXN) +8.7% pre-market Tuesday after unveiling a broad strategic restructuring of its ...

Virco Manufacturing Corporation has delivered nearly 40% returns this year, outperforming micro-caps and industrial stocks ...

ZIM Integrated Shipping Services Ltd. (NYSE:ZIM) is up over 200% in the last year, thanks to strong results and improved ...

Adaptive Biotechnologies posted strong Q3 results, beating expectations and reducing losses, while management has done a good ...

Cassava Sciences (SAVA) stock faces uncertainty after a major late-stage trial setback for the company's Alzheimer's candiate ...

ACV offers a hybrid portfolio with a focus on convertibles but also incorporating equities, and high-yield bonds. Read why I ...

PENN's online efforts with ESPN Bet continue to strain earnings without significant market share gains. See why I rate PENN ...

Trinity Capital offers a high, well-covered 14.2% dividend yield, supported by strong net investment income and record loan ...

Smart Logistics Global Limited has filed proposed terms for a $5.5 million IPO. The risks it faces, its financial results and ...

CoinShares Valkyrie Bitcoin Miners ETF sees potential in Bitcoin’s rally. Read why WGMI’s concentrated portfolio and high ...

DHL Group (DPSTF) shares have declined due to higher costs, weakening demand, and potential U.S. tariffs. Check out why I ...